The ship has a range of 16,000 nautical miles, which is equivalent to about 18,392 miles. It’s also being claimed that the vessel can go to speeds exceeding 15 knots and traverse areas with ...

It’s now the first new treatment in 70 years for CAH, delivering a non-glucocorticoid approach to decrease adrenocorticotropic hormone [ACTH] and adrenal androgen generation. This matters ...

Crenessity is expected to be available commercially in approximately 1 week through PANTHERx Rare, a specialty pharmacy. The Food and Drug Administration (FDA) has approved Crenessity TM ...

Background: Glucocorticoid-induced adrenal insufficiency (GIAI) is a hypothalamic-pituitary-adrenal (HPA) axis dysfunction caused by long-term use of exogenous steroids. Adrenal crisis (AC) is an ...

CAHmelia-204 trial missed its primary goal of reducing daily glucocorticoid use in adults ... dose of 35mg/day of hydrocortisone equivalents (HCe) (19mg/m2/day) and mean androstenedione (A4 ...